• Our Story
  • Brand
  • Heritage
    • Our Founder
    • Milestones
    • An Unfinished Agenda
  • Leadership
    • Board Of Directors
    • Management Council
  • Featured Stories
• Our Products
  • Business Porfolio
    • Generics
    • Over-the-counter
    • APIs
    • Biologics
    • Differentiated Formulations
    • Services
  • Quality
  • Therapeutic Focus
• Our Science
  • Research Philosophy
  • Development Streams
    • Generics
    • APIs
    • Biologics
    • Proprietary Products
  • Capabilities
• Our People
  • Life at Dr.Reddy's
  • Humans of Dr. Reddy’s
• Our Citizenship
  • Patients
  • Healthcare Professionals
  • Community
    • Our Approach
    • Education
    • Livelihoods
    • Healthcare
    • Change Makers
  • Planet
    • Commitment to the Planet
    • Initiatives
    • Carbon Footprint
  • Affiliates
    • Dr Reddy’s Foundations
    • Partners
  • Sustainability
• Investors
  • Reports and Filings
    • Annual Reports
    • Quarterly Reports
    • SEC Filings
    • 34^th Annual General Meeting
    • AGM Voting Results
    • MoA and AoA
  • Presentations
    • Presentations
    • Earnings Call Notification
    • Earnings Call
  • Shares
    • Closure of Buyback
    • Share Price
    • Stock Updates
    • Equity & Dividend History
    • Unpaid & Unclaimed Dividend
    • Analyst Coverage
    • Shareholding Pattern
    • Share Transfer Information
    • Buyback
    • Details of Shares for transfer to IEPF August 17
    • Notice pursuant to IEPF Rules, Aug 17
    • Details of Shares for transfer to IEPF May 2018
    • Notice pursuant to IEPF Rules, May 2018
  • Governance
    • Internal Control Systems
    • Committees of the Board
    • Code of Business Conduct and Ethics (COBE)
    • Ombudsperson Policy
    • Supplier Code of Conduct
    • Compliance with NYSE
    • Information to Stakeholders
    • Corporate Governance Reports
    • Policies and Documents
    • Data Privacy Notice
  • Investor Services
    • Statutory Communication
    • Shareholder’s Contacts
    • Management Call Notification
    • Shareholder Information
    • Investor Meeting Details
    • Other Stock Exchange Intimations
• Media
  • Press Releases
  • Media Kit
  • Dr Reddy's in the news
• Partners
  • Prospective Partners
  • Post an Enquiry
  • Login for Current Partners
• Canada
  • Dr. Reddy's in Canada
  • Our Products
  • Medical Information
  • Patient Care Program
  • Customer Service
  • Contact Us
• Australia
  • Dr. Reddy's in Australia
  • Our Products
  • Our Programmes
  • Contact Us
• Germany
  • Dr. Reddy's in Germany
  • Our Products
  • CONTACT Us
• India
  • Dr.Reddy’s in India
  • Portfolio
    • Top Brands
    • Biosimilars
    • Differentiated Products
    • OTC List
    • Therapy Areas
  • Programs
    • For Doctors
    • For Patients
    • DRFHE
  • People
    • Working with Dr.Reddy's
    • Careers
  • Medical Information
  • Contact Us
• New Zealand
  • Dr. Reddy's in New Zealand
  • Contact Us
• China
  • Contact Us
  • Our Products
  • Dr. Reddy's in China
• Netherlands
  • Dr. Reddy’s Research and Development
  • Contact Us
  • Our Products
• Contact Us
  • Global Locations
  • Key Contacts
  • Medical Information